Affectis Pharmaceuticals AG, of Munich, Germany, appointed Jesper Wiklund chief business officer and head of finance...Galenea Corp., of Cambridge, Mass., appointed Mark Benjamin president and CEO

La Jolla Pharmaceutical Co., of San Diego, hired Niv Caviar as executive vice president, chief business officer and chief financial officer...Pharmacopeia Drug Discovery Inc., of Princeton, N.J., elected Martin Soeters and Dennis Langer to its board...Poniard Pharmaceuticals Inc., of South San Francisco, appointed Ronald Martell president and chief operating officer

AEterna Zentaris Inc., of Quebec City, named Ellen McDonald senior vice president, business operations and chief business officer, and named Nicholas Pelliccione senior vice president, regulatory affairs and quality assurance

Sloning Biotechnology, of Puchheim, Germany, appointed Thomas Matthes chief business officer...and Boston, appointed Claude Benedict senior vice president, clinical development and regulatory affairs

Diamics Inc., of Novato, Calif., named Mitchell Golbus chief medical and technical officer...Dyax Corp., of Cambridge, Mass., is hiring Gustav Christensen as executive vice president and chief business officer

Ardea Biosciences Inc., of Carlsbad, Calif., hired Christopher Krueger as senior vice president and chief business officer, and Colin Rowlings as senior vice president of pharmaceutical sciences

Affitech, of Oslo, Norway, named Hans Petter Tjeldflaat as director of finance and Rathin Das as senior vice president of corporate development and chief business officer...ARCA Discovery, of Denver, named Dick Brewer president, CEO and member of the board

Avalon Pharmaceuticals Inc., of Germantown, Md., appointed David Muth as executive vice president and chief business officer...Fovea Pharmaceuticals SA, of Paris, appointed Gary Jay Sternberg as senior vice president and chief business officer

Neogen Corp., of Lansing, Mich., appointed Lon Bohannon president and chief operating officer...Nereus Pharmaceuticals Inc., of San Diego, appointed Charles White chief business officer...Oxigene Inc., of Waltham, Mass., appointed Richard Chin president and CEO

and Antonio Gotto to its board and scientific advisory board...Avidia Inc., of Mountain View, Calif., appointed Paulette Dillon senior vice president and chief business officer

Onyx Pharmaceuticals Inc., of Emeryville, Calif., appointed Laura Brege executive vice president and chief business officer...Penwest Pharmaceuticals Co., of Danbury, Conn., appointed Jennifer Good CEO and a member of its board

and Jeff Silverman vice president, operations integration and new technology development...John Weidenbruch as general counsel and assistant corporate secretary

Synta Pharmaceuticals Corp., of Lexington, Mass., appointed Martin Williams vice president of business and commercial development and chief business officer...Zelos Therapeutics Inc., of West Conshohocken, Pa., appointed Jay Mohr chief business officer and Martin Stogniew executive vice president of development

and David Schenkein vice president, clinical hematology and oncology...and William Kelly vice president, investor relations and corporate communications

Syngenta, of Basel, Switzerland, appointed Carsten Tilger head of communication and public affairs...Tracon Pharmaceuticals Inc., of San Diego, appointed Bryan Leigh chief medical officer, Mazen Skaf chief business officer, Elizabeth Clark Moore vice president of regulatory affairs, and Kim Weinberger head of clinical operations...Xention Discovery Ltd., of Cambridge, UK, appointed Kenneth Cunningham and Wolfgang Hartwig nonexecutive directors

and it added four other new vice presidents: Allan Darling for corporate quality control, Garry Ebbert for antibody and small-molecule manufacturing, Bahija Jallal for translational sciences, and Douglas Willner for sales training...Morphotek Inc., of Exton, Pa., appointed Robert Radie chief business officer, and promoted Luigi Grasso to senior vice president of research and development

Infinity Pharmaceuticals Inc., of Cambridge, Mass., appointed Julian Adams president and chief scientific officer, Adelene Perkins executive vice president and chief business officer, and David Grayzel vice president, clinical development and medical affairs

Vasogen Inc., of Toronto, appointed Ronald Cresswell and Calvin Stiller to its board...Vion Pharmaceuticals Inc., of New Haven, Conn., appointed Meghan Fitzgerald chief business officer...Mary Haak-Frendscho vice president, preclinical research and development

Xenome Ltd., of Brisbane, Australia, and San Diego, appointed David Slack chief business officer